Journal of Medical GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
A Comprehensive Epithelial Tubo-Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors
Andrew LeeiD, Xin YangiD, Jonathan P. TyreriD, Aleksandra Gentry‐MaharajiD, Andy RyaniD, Nasim MavaddatiD, Alex P Cunningham, Tim J. CarveriD, Stephanie ArcheriD, Goska LeslieiD, Jatinder Kalsi, Faiza GabaiD, Ranjit ManchandaiD, Simon A. GaytheriD, Susan J. RamusiD, Fiona Mary WalteriD, Marc D. TischkowitziD, Ian J. JacobsiD, Usha MenoniD, Douglas F. EastoniD, Paul D.P. PharoahiD, Antonis C. AntoniouiD
Abstract
BackgroundEpithelial tubo-ovarian cancer (EOC) has high mortality partly due to late diagnosis. Prevention is available but may be associated with adverse effects. A multifactorial risk model based on known genetic and epidemiological risk factors (RFs) for EOC can help identify females at higher risk who could benefit from targeted screening and prevention. MethodsWe developed a multifactorial EOC risk model for females of European ancestry incorporating the effects of pathogenic variants (PVs) in BRCA1, BRCA2, RAD51C, RAD51D and BRIP1, a polygenic risk score (PRS) of arbitrary size, the effects of RFs and explicit family history (FH) using a synthetic model approach. The PRS, PV and RFs were assumed to act multiplicatively. ResultsBased on a currently available PRS for EOC that explains 5% of the EOC polygenic variance, the estimated lifetime risks under the multifactorial model in the general population vary from 0.5% to 4.6% for the 1st to 99th percentiles of the EOC risk-distribution. The corresponding range for females with an affected first-degree relative is 1.9% to 10.3%. Based on the combined risk distribution, 33% of RAD51D PV carriers are expected to have a lifetime EOC risk of less than 10%. RFs provided the widest distribution, followed by the PRS. In an independent partial model validation, absolute and relative 5-year risks were well-calibrated in quintiles of predicted risk. ConclusionThis multifactorial risk model can facilitate stratification, in particular among females with FH of cancer and/or moderate- and high-risk PVs. The model is available via the CanRisk Tool (www.canrisk.org).
- organism: human
- assay: GWAS summary statistics
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 60
- FWCI
- 5.79
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1, updates to tumour pathology and cancer incidences.
Andrew Lee, Nasim Mavaddat, … Antonis C. Antoniou·Journal of Medical GeneticsPeer-reviewed·Sep 26, 2022
- Precision Breast Cancer Screening with a Polygenic Risk Score
Tõnis Tasa, Mikk Puustusmaa, … Peeter Padrik·medRxiv·Aug 17, 2020
- Genomic risk prediction for breast cancer in older women
Paul A Lacaze, Andrew Bakshi, … John J. McNeil·CancersPeer-reviewed·Jul 14, 2021
- Population based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high grade serous ovarian cancer
Honglin Song, Ed Dicks, … Paul D.P. Pharoah·Journal of Medical GeneticsPeer-reviewed·Jun 16, 2020
- Genetic risk score for ovarian cancer based on chromosomal-scale length variation.
Christopher Toh, James P. Brody·BioData MiningPeer-reviewed·Mar 9, 2021
- eTumorRisk, an algorithm predicts cancer risk based on comutated gene networks in an individual’s germline genome
Jinfeng Zou, Edwin Wang·bioRxiv·Aug 16, 2018